Adjunct Assistant Professor, Department of Pediatrics (Pediatric Hematology/Oncology), UCSF
Education
Pennsylvania State University, University Park, PA, BS, 1990-1994, Biology
University of Maryland, Baltimore, MD, MD, 1994-1998, Medicine
University of California, San Francisco, CA, Resident, 1998-2001, Pediatrics
University of California, San Francisco, CA, 2001-2002, Oncology Research
University of California, San Francisco, CA, Fellow, 2002-2006, Hematology/Oncology
Professional Experience
- 1998-2001
Resident, Department of Pediatrics, University of California, San Francisco
- 2001-2002
Research fellow, Laboratory of Kevin Shannon, M.D., University of California, San Francisco (Project: Candidate tumor suppressor gene on 7q22)
- 2002-2005
Fellow, Pediatric Hematology/Oncology, University of California, San Francisco
- 2005-2006
Postdoctoral Research Fellow, Pediatric Hematology/Oncology, University of California, San Francisco
- 2006-Present
Adjunct Assistant Professor, Pediatric Hematology/Oncology, University of California, San Francisco
Honors & Awards
- 1993
Jean P. Shibley Biology Scholarship, The Pennsylvania State University - 1997
Alpha Omega Alpha Honor Society, University of Maryland School of Medicine - 1998
J. Edmund Bradley Award for Excellence in Pediatrics, University of Maryland School of Medicine - 1998
Faculty Gold Medal Award for Outstanding Qualification for Practice of Medicine (awarded to one student yearly for academic and clinical excellence), University of Maryland School of Medicine - 1998
Summa Cum Laude, University of Maryland School of Medicine - 2006
Melvin Grumbach Research Award UCSF Pediatric Department - 2006
American Society of Pediatric Hematology/Oncology (ASPHO) Best of ASPHO Abstract Award - 2003-present
Campini Fellowship, University of California, San Francisco
Selected Publications
- Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 2004; 103: 4243-4250.
- Curtiss NP*, Bonifas JM*, Lauchle JO*, Balkman JD, Kratz CP, Emerling BM, Green ED, Le Beau MM, Shannon KM. Isolation and Analysis of Candidate Myeloid Tumor Suppressor Genes from a Commonly Deleted Segment of 7q22. Genomics 2005; 85: 600-607*- These authors contributed equally to this work.
- Lauchle JO, Bran BS, Loh ML, and Shannon KM. Inherited Predispositions and Hyperactive Ras in Myeloid Leukemogenesis. Pediatric Blood and Cancer 2006; 46: 579-85
- Kim A, Morgan K, Hasz DE, Weisner SM, Lauchle JO, Geurts JL, Diers MD, Le DT, Kogan SC, Parada LF,Shannon K, Largaespada DA. Beta Common Receptor Inactivation Attenuates Myeloproliferative Disease in Nf1 Mutant Mice, Blood 2004; 103: 4243-4250.
